Search Videos and More
Comprehensive Cancer Care for the Doral Community
Baptist Health Cancer Care is now serving patients in Doral with a comprehensive, community-based approach to oncology care designed to make treatment more convenient and accessible for both patients and referring physicians.New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care
New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.Baptist Health Foundation Announces Historic $100 Million Gift from Dr. Herbert Wertheim
Baptist Health Foundation announced the largest single philanthropic gift in the 66-year history of Baptist Health South FloridaFirst Patient Treated with Proton Therapy at Lynn Cancer Institute
The Eugene M. & Christine E. Lynn Cancer Institute at Boca Raton Regional Hospital, part of Baptist Health, reached an important milestone in the advancement of cancer care with the successful treatment of its first patient utilizing proton therapy, according to physicians at both the Institute and the hospital.Eugene M. & Christine E. Lynn Cancer Institute Treats First Patient with Tarlatamab, Expanding Advanced Therapeutic Options for Patients with Refractory Malignancies
Eugene M. & Christine E. Lynn Cancer Institute has treated its first patient with tarlatamab, marking an important milestone in the expansion of advanced cancer therapies available to patients in Palm Beach County and the surrounding region.Experimental Daraxonrasib Shows Promise in Advanced Pancreatic Cancer
Metastatic pancreatic ductal adenocarcinoma remains one of the most challenging malignancies to treat in clinical oncology.Proton Therapy in Early-Onset Locally Advanced Rectal Cancer: The Importance of Fertility-Preserving Multimodality Care
The rising incidence and mortality of early-onset colorectal cancer (EOCRC), defined as disease occurring in patients younger than 50, has emerged as a clinically significant trend with implications for screening, diagnosis, and survivorship.Complex Hematologic Malignancy Management in a TP53-Mutated Patient: Balancing Disease Control and Quality of Life
Cytogenetic and molecular testing revealed a complex karyotype and a TP53 mutation, placing her disease in an adverse-risk category.Clinical Strategies for Preserving Fertility in Male Cancer Patients
Urologist Justin Dubin, M.D., director of Men’s Sexual Health at Baptist Health Miami Cancer Institute, emphasizes that fighting cancer and preserving fertility are not mutually exclusive.Oral and Head and Neck Cancers Rising: What You Need to Know
Most people know that tobacco use is a major risk factor for oral and head and neck cancers. Some even understand that excessive alcohol consumption also ups the odds.Innovations Shaping Women’s Cancer Care in 2026
As we move through 2026, new technologies and refined surgical techniques are transforming outcomes for women facing cancer diagnoses.Miami Cancer Institute Leads Landmark Phase 2 Glioblastoma Trial
The randomized Phase 2 CRUX-2 trial (Ruxolitinib in Combination with Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma) is currently recruiting.
